Compounded Tirzepatide Recall: Which Vials Are Affected and What Is Known
A North Carolina compounding pharmacy has recalled injectable drugs nationwide, including compounded versions of the GLP-1 medication tirzepatide, because their sterility cannot…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 21 03:08 ETSource: Around Prague
From the source
Read at aroundprague.czCompounded Tirzepatide Recall: Which Vials Are Affected and What Is Known
A North Carolina compounding pharmacy has recalled injectable drugs nationwide, including compounded versions of the GLP-1 medication tirzepatide, because their sterility cannot be assured, according to a Food and Drug Administration notice reported by USA Today, Fox Business and Cardinal & Pine.
